Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析

◆英語タイトル:Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1676
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Arena Pharmaceuticals Inc (ARNA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Arena Pharmaceuticals Inc (Arena) is a biopharmaceutical company which discovers, develops and commercializes small molecule drugs in multiple therapy areas. The company’s major product candidates include etrasimod, an oral sphingosine 1-phosphate receptor modulator intended for the treatment of gastroenterology and dermatology disease areas such as ulcerative colitis, eosinophilic esophagitis, Crohn’s disease, atopic dermatitis, and alopecia areata; Olorinab for pain associated with inflammatory bowel diseases and irritable bowel syndrome; APD418 for acute heart failure; and Ralinepag for the treatment of pulmonary arterial hypertension (PAH). It has collaborations with United Therapeutics, Eisai, Everest Medicines Limited, Boehringer Ingelheim and Beacon Discovery Inc. It has manufacturing facility in Zofingen, Switzerland. Arena is headquartered in San Diego, California, the US.

Arena Pharmaceuticals Inc Key Recent Developments

Mar 30,2020 Arena Pharmaceuticals names James C. Mullen as an Independent Senior Advisor
Feb 26,2020 Arena announces management and program updates and reports fourth quarter and full-year 2019 financial results
Jan 06,2020 Arena Pharmaceuticals highlights strategic plan driving near and long-term growth with eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND per year for the next 5 years
Jan 02,2020 Arena Pharmaceuticals and Beacon Discovery expand strategic relationship focusing on multiple immune and inflammatory targets

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Arena Pharmaceuticals Inc – Key Facts
Arena Pharmaceuticals Inc – Key Employees
Arena Pharmaceuticals Inc – Key Employee Biographies
Arena Pharmaceuticals Inc – Major Products and Services
Arena Pharmaceuticals Inc – History
Arena Pharmaceuticals Inc – Company Statement
Arena Pharmaceuticals Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Arena Pharmaceuticals Inc – Business Description
R&D Overview
Arena Pharmaceuticals Inc – Corporate Strategy
Arena Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Arena Pharmaceuticals Inc – Strengths
Arena Pharmaceuticals Inc – Weaknesses
Arena Pharmaceuticals Inc – Opportunities
Arena Pharmaceuticals Inc – Threats
Arena Pharmaceuticals Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Arena Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 30, 2020: Arena Pharmaceuticals names James C. Mullen as an Independent Senior Advisor
Feb 26, 2020: Arena announces management and program updates and reports fourth quarter and full-year 2019 financial results
Jan 06, 2020: Arena Pharmaceuticals highlights strategic plan driving near and long-term growth with eight Ph 2 and Ph 3 Data Readouts in 2020-21 and One New IND per year for the next 5 years
Jan 02, 2020: Arena Pharmaceuticals and Beacon Discovery expand strategic relationship focusing on multiple immune and inflammatory targets
Nov 18, 2019: California Life Sciences Association honors Arena Pharmaceuticals at the Pantheon 2019 DiNA awards for the deal of the year
Nov 07, 2019: Arena reports third quarter financial results with continued progress on clinical programs
Aug 07, 2019: Arena reports second quarter financial results with strong liquidity position, and initiation of etrasimod ELEVATE UC 52 and olorinab CAPTIVATE Trials
May 08, 2019: Arena Pharmaceuticals provides corporate update and reports first quarter 2019 financial results
Feb 26, 2019: Arena Pharmaceuticals provides corporate update and reports fourth quarter and full-year 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Arena Pharmaceuticals Inc, Key Facts
Arena Pharmaceuticals Inc, Key Employees
Arena Pharmaceuticals Inc, Key Employee Biographies
Arena Pharmaceuticals Inc, Major Products and Services
Arena Pharmaceuticals Inc, History
Arena Pharmaceuticals Inc, Other Locations
Arena Pharmaceuticals Inc, Subsidiaries
Arena Pharmaceuticals Inc, Key Competitors
Arena Pharmaceuticals Inc, Ratios based on current share price
Arena Pharmaceuticals Inc, Annual Ratios
Arena Pharmaceuticals Inc, Annual Ratios (Cont...1)
Arena Pharmaceuticals Inc, Interim Ratios
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Arena Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Arena Pharmaceuticals Inc, Performance Chart (2015 - 2019)
Arena Pharmaceuticals Inc, Ratio Charts
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Arena Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tribune Media Company:企業の戦略・SWOT・財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Christian Dior SE:企業の戦略・SWOT・財務情報
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Strategic Resources Inc (STI):企業の財務・戦略的SWOT分析
    Strategic Resources Inc (STI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Challenger Ltd.:企業の戦略・SWOT・財務情報
    Challenger Ltd. - Strategy, SWOT and Corporate Finance Report Summary Challenger Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Credit Agricole CIB S.A.:企業の戦略的SWOT分析
    Credit Agricole CIB S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • The Hain Celestial Group, Inc.:戦略・SWOT・企業財務分析
    The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hain Celestial Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gartner Inc (IT):企業の財務・戦略的SWOT分析
    Gartner Inc (IT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • DHX Media Ltd.:企業の戦略・SWOT・財務情報
    DHX Media Ltd. - Strategy, SWOT and Corporate Finance Report Summary DHX Media Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • John B. Sanfilippo & Son Inc:企業の戦略・SWOT・財務分析
    John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report Summary John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • People’S Bank:企業の戦略・SWOT・財務分析
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Integra LifeSciences Holdings Corp (IART):企業の財務・戦略的SWOT分析
    Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Traverse Energy Ltd (TVL):企業の財務・戦略的SWOT分析
    Summary Traverse Energy Ltd (Traverse Energy), formerly Firstland Energy Ltd is an oil and gas company that explores, produces, and develops petroleum and natural gas assets. The company's products include crude oil, natural gas, petroleum products, and associated liquids, among others. It explores …
  • TE Connectivity Ltd.:企業の戦略・SWOT・財務情報
    TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report Summary TE Connectivity Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • 1-800-FLOWERS.COM, Inc. (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM, Inc. (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Smith & Nephew Plc (SN.):企業の財務・戦略的SWOT分析
    Smith & Nephew Plc (SN.) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • DBS Bank (Hong Kong) Limited:企業の戦略・SWOT・財務情報
    DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report Summary DBS Bank (Hong Kong) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • USG Corporation:企業の戦略・SWOT・財務情報
    USG Corporation - Strategy, SWOT and Corporate Finance Report Summary USG Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Transocean Ltd.:企業の戦略・SWOT・財務情報
    Transocean Ltd. - Strategy, SWOT and Corporate Finance Report Summary Transocean Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Sapura Energy Bhd (SENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Sapura Energy Bhd (Sapura) formerly known as SapuraKencana Petroleum Berhad is a global provider of integrated oil and gas services and solutions. It focuses on upstream business covering exploration, development, production, as well as decommissioning and abandonment stages. The company’s s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆